Polygenic Risk Score Predicts Radiographic Progression in Rheumatoid Arthritis
Researchers determined the role of polygenic risk scores in predicting radiographic progression in rheumatoid arthritis.
Researchers determined the role of polygenic risk scores in predicting radiographic progression in rheumatoid arthritis.
With no large scale studies examining mental health among transgender and nonbinary youth who receive gender affirming hormone therapy (GAHT), researchers investigated connections with access to GAHT and thoughts of suicide, attempted suicide, and depression among transgender and nonbinary youth.
Researchers assessed the prevalence and risk factors for opioid use in patients with knee osteoarthritis.
Researchers studied the humoral and cellular immune responses after 2 or 3 doses of SARS-CoV-2 vaccines in patients with rheumatoid arthritis receiving treatment with rituximab.
Authors of a systematic review assessed the quality of consensus-based rheumatology recommendations and identified the types and extent of pharmaceutical industry involvement.
Study data published in Neuropsychiatric Disease and Treatment outline the primary factors affecting attrition in buprenorphine treatment for opioid use disorder.
The safety and efficacy of ustekinumab was determined in a phase 2 trial for the treatment of recurrent oral ulcers in Behçet disease.
The benefits of physical activity on quality of life and function in patients with rheumatoid arthritis (RA) are supported in this meta-analysis.
Researchers studied the association between ANCA-associated vasculitis and adverse cardiovascular outcomes.
In a case study, Dr de Carvalho describes the successful use of alternative and complementary medicine in a patient with ankylosing spondylitis after cessation of adalimumab therapy.